Obesity and associated cardiovascular and metabolic diseases are among our most important health problems and major economic challenges in health systems around the country quickly. Mississippi currently leads the nation in obesity in adults and in children.
A summit that will both scientific and business policy forum meeting place Mississippi at the front of fighting obesity and metabolic diseases like diabetes.The company also provides sterilization and ionization solutions solutions to the hygiene and security in everyday life improving. The overall European the pan-European stock exchange EURONEXT, is one of the BelMid index of. The IBA leader roller the area of molecular imaging by the constant innovative for grown his technology, and built on the worldwide radiopharmaceutical agents distribution network is. By to a growing number of facilities in North America Europe and Asia, by which IBA continue make radiopharmaceutical agents, day mostly FDG, alignment of the cellso hospitals and imaging centers all over the world.
About APOSENSE technologicalAPOSENSE a proprietary new class of from rationally small molecules to identify small molecules that selectively accumulate within apoptotic cells in vivo. Apoptotic plays a role in in many diseases numerous clinical fields, including oncology, neurology and cardiology. Molecular imaging with APOSENSE enables real time visualization for of biological activity of disease, their formation, change course and response to treatment and handling for the individual patient personalizing. Therapeutic uses of technology in preclinical develop be APOSENSE cancer therapy which use apoptotic cells into tumors as targets for specific Shipping of anticancer drugs to the tumor. APOSENSE technology was NST Neurosurgery Survival player Technologies, a molecular imaging techniques in the clinical and development of drugs company that, the introduction of of new imaging and therapeutic drugs through the alignment of cells The ability to role undergoing apoptosis focuses develops.